2′-Amino-5′-chloro-2,2,2-trifluoroacetophenone

We are 2′-Amino-5′-chloro-2,2,2-trifluoroacetophenone CAS:214353-17-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2'-Amino-5'-chloro-2,2,2-trifluoroacetophenone
CAS.NO:214353-17-0
Synonyms:2'-Amino-5'-chloro-2,2,2-trifluoroacetophenone
2-[5-chloro-2-(hydroxyaMino)phenyl]-2,2-difluoroacetyl fluoride hydrochloride
1,1-ETHANEDIOL,1-(2-AMINO-5-CHLOROPHENYL)-2,2,2-TRIFLUORO-,HYDROCHLORIDE
2-Amino-5-chlorophenyl-2,2,2-trifluoroethanone
2'-AMino-5'-chloro-2,2,2-trifluoroacetophenone hydrochloride Monohydrate
 
Physical and Chemical Properties:
Density 1.624g/cm3
Boiling Point 381.771ºC at 760 mmHg
Molecular Formula C8H8Cl2F3NO2
Molecular Weight 278.05600
Flash Point 184.689ºC
Vapour Pressure 0mmHg at 25°C
Index of Refraction 1.559
 
Specification:
Appearance:White to light yellow crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Efavirenz(CAS:154598-52-4).

2'-Amino-5'-chloro-2,2,2-trifluoroacetophenone


Related News: In August, the Company announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 10,370,452 covering compositions and uses of effector T cells expressing a CAR, where such T cells are derived from a pluripotent stem cell, including an iPSC.3 ', 5'-Bis-O- (4-clorobenzoil) -2-desoxi-5-azacitosina CAS:1034301-08-0 By drawing these distinctions between APIs and the drugs themselves, manufacturers are able to specialize and pharmacists able to align generic equivalents with brand names.fluoranthen-3-amine CAS:2693-46-1 International Chemical Investors Group (ICIG) recently announced it has entered into a purchase agreement under which an affiliate of ICIG will acquire the pharmaceutical intermediates business from Genzyme Corporation.3-amino-2-bromo-5-fluoropiridina CAS:884495-03-8 China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.Dr. John K. Westwick, CEO of Resonant, added “Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates.

Related Products
Product Name
Coenzyme Q10 View Details
Tetrakis(butoxyethoxy)silane View Details
3-t-Butoxycarbonylphenylboronic acid View Details
4-N-(3-chloro-4-fluorophenyl)-7-(3-morpholin-4-ylpropoxy)quinazoline-4,6-diamine manufacturer 6-bromo-1H-pyridin-2-one manufacturer methyl 4-(chlorocarbonothioyloxy)benzoate manufacturer Potassium selenocyanat manufacturer Polyhexamethyleneguanidine hydrochloride manufacturer